FDA updates oral nizoral label to reflect safety concerns

(HealthDay)—The U.S. Food and Drug Administration has approved label changes for Nizoral (ketoconazole) oral tablets and added a Medication Guide detailing various associated safety concerns. Nizoral tablets can cause liver injury, potentially necessitating transplantation or resulting in…

Source:FDA updates oral nizoral label to reflect safety concerns